Compugen | CGEN - Equity Capital And Reserves


Compugen reported $95.35M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Arca Biopharma USD 1.11B 627.83M Jun/2026
aTyr Pharma USD 48.79M 9.15M Jun/2026
Bio Path USD -8.49M 482K Mar/2026
Brainstorm Cell Therapeutics USD -11.6M 588K Jun/2026
Cara Therapeutics USD 14.5M 6.44M Mar/2026
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 95.35M 7.38M Mar/2026
Immunic USD 151.23M 157.91M Mar/2026
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
RedHill Biopharma USD 4.27M 8.68M Dec/2025
TherapeuticsMD USD 27.67M 990K Jun/2024